Acelyrin Balance Sheet Health
Financial Health criteria checks 6/6
Acelyrin has a total shareholder equity of $528.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $618.3M and $90.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$562.37m |
| Equity | US$528.28m |
| Total liabilities | US$90.03m |
| Total assets | US$618.31m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: SLRN's short term assets ($596.6M) exceed its short term liabilities ($83.5M).
Long Term Liabilities: SLRN's short term assets ($596.6M) exceed its long term liabilities ($6.6M).
Debt to Equity History and Analysis
Debt Level: SLRN is debt free.
Reducing Debt: SLRN has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SLRN has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: SLRN has sufficient cash runway for 3 years if free cash flow continues to reduce at historical rates of 63% each year.